15 results on '"Wen-Der Lin"'
Search Results
2. Data from Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer
- Author
-
Alice L. Yu, John Yu, Li-Mei Pai, Kay-Hooi Khoo, Chu-Wei Kuo, Sheng-Hung Wang, Hui-Ling Yeo, Jung‐Tung Hung, Tan-Chi Fan, and Wen-Der Lin
- Abstract
Altered glycosylations, which are associated with expression and activities of glycosyltransferases, can dramatically affect the function of glycoproteins and modify the behavior of tumor cells. ST3GAL1 is a sialyltransferase that adds sialic acid to core 1 glycans, thereby terminating glycan chain extension. In breast carcinomas, overexpression of ST3GAL1 promotes tumorigenesis and correlates with increased tumor grade. In pursuing the role of ST3GAL1 in breast cancer using ST3GAL1-siRNA to knockdown ST3GAL1, we identified CD55 to be one of the potential target proteins of ST3GAL1. CD55 is an important complement regulatory protein, preventing cells from complement-mediated cytotoxicity. CD55 had one N-linked glycosylation site in addition to a Ser/Thr-rich domain, which was expected to be heavily O-glycosylated. Detailed analyses of N- and O-linked oligosaccharides of CD55 released from scramble or ST3GAL1 siRNA–treated breast cancer cells by tandem mass spectrometry revealed that the N-glycan profile was not affected by ST3GAL1 silencing. The O-glycan profile of CD55 demonstrated a shift in abundance to nonsialylated core 1 and monosialylated core 2 at the expense of the disialylated core 2 structure after ST3GAL1 silencing. We also demonstrated that O-linked desialylation of CD55 by ST3GAL1 silencing resulted in increased C3 deposition and complement-mediated lysis of breast cancer cells and enhanced sensitivity to antibody-dependent cell-mediated cytotoxicity. These data demonstrated that ST3GAL1-mediated O-linked sialylation of CD55 acts like an immune checkpoint molecule for cancer cells to evade immune attack and that inhibition of ST3GAL1 is a potential strategy to block CD55-mediated immune evasion.
- Published
- 2023
3. ICAM2 initiates trans-Blood-CSF barrier migration and stemness properties in leptomeningeal metastasis of triple-negative breast cancer
- Author
-
Pei-Jung Lu, Jhih-Kai Pan, Wen-Der Lin, Yao-Lung Kuo, Yu-Chia Chen, Zhu-Jun Loh, Forn-Chia Lin, Hui-Chuan Cheng, and Michael Hsiao
- Abstract
Leptomeningeal metastasis (LM) occurs when tumor cells spread to the leptomeningeal space surrounding the brain and the spinal cord, thereby causing poor clinical outcomes. The triple-negative breast cancer (TNBC) has been associated with symptoms of LM and mechanism remained unclear. Through proteomic analysis, we identified high expression of ICAM2 in leptomeningeal metastatic TNBC cells, which promoted the colonization of the spinal cord and resulted in poor survival in vivo. Two-way demonstration indicated that high levels of ICAM2 promoted blood–cerebrospinal fluid barrier (BCB) adhesion, trans-BCB migration, and stemness abilities and determined the specificity of LM in vivo. Furthermore, pulldown and antibody neutralizing assay revealed that ICAM2 determined the specificity of LM through interactions with ICAM1 in the choroid plexus epithelial cells. Therefore, neutralizing ICAM2 can attenuate the progression of LM and prolong survival in vivo. The results suggested that targeting ICAM2 is a potential therapeutic strategy for LM in TNBC.
- Published
- 2022
4. Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer
- Author
-
Cheng-Han Lin, Wen-Der Lin, Yun-Chin Huang, Yu-Chia Chen, Zhu-Jun Loh, Luo-Ping Ger, Forn-Chia Lin, Hao-Yi Li, Hui-Chuan Cheng, Kuen-Haur Lee, Michael Hsiao, and Pei-Jung Lu
- Subjects
Cancer Research ,Molecular Medicine ,Molecular Biology - Abstract
Currently, the survival rate for breast cancer is more than 90%, but once the cancer cells metastasize to distal organs, the survival rate is dramatically reduced, to less than 30%. Triple-negative breast cancer accounts for 15-20% of all breast cancers. Triple-negative breast cancer (TNBC) is associated with poor prognostic and diagnostic outcomes due to the limiting therapeutic strategies, relative to non-TNBC breast cancers. Therefore, the development of targeted therapy for TNBC metastasis remains an urgent issue. In this study, high Carboxyl-terminal modulator protein (CTMP) is significantly associated with recurrence and disease-free survival rate in TNBC patients. Overexpression of CTMP promotes migration and invasion abilities in BT549 cells. Down-regulating of CTMP expression inhibits migration and invasion abilities in MDA-MB-231 cells. In vivo inoculation of high-CTMP cells enhances distant metastasis in mice. The metastasis incidence rate is decreased in mice injected with CTMP-downregulating MDA-MB-231 cells. Gene expression microarray analysis indicates the Akt-dependent pathway is significantly enhanced in CTMP overexpressing cells compared to the parental cells. Blocking Akt activation via Akt inhibitor treatment or co-expression of the dominant-negative form of Akt proteins successfully abolishes the CTMP mediating invasion in TNBC cells. Our findings suggest that CTMP is a potential diagnostic marker for recurrence and poor disease-free survival in TNBC patients. CTMP promotes TNBC metastasis via the Akt-activation-dependent pathway.
- Published
- 2022
5. Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer
- Author
-
Wen-Der Lin, Jung-Tung Hung, Chu-Wei Kuo, Sheng-Hung Wang, Alice L. Yu, Li-Mei Pai, Kay-Hooi Khoo, John Yu, Hui-Ling Yeo, and Tan-Chi Fan
- Subjects
0301 basic medicine ,Cancer Research ,Glycosylation ,beta-Galactoside alpha-2,3-Sialyltransferase ,Sialyltransferase ,Immunology ,Breast Neoplasms ,medicine.disease_cause ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Immune system ,Cell Line, Tumor ,medicine ,Humans ,RNA, Small Interfering ,Cytotoxicity ,Immune Evasion ,CD55 Antigens ,biology ,Antibody-Dependent Cell Cytotoxicity ,Cancer ,medicine.disease ,Sialyltransferases ,Immune checkpoint ,Cell biology ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,Cancer cell ,biology.protein ,Carcinogenesis - Abstract
Altered glycosylations, which are associated with expression and activities of glycosyltransferases, can dramatically affect the function of glycoproteins and modify the behavior of tumor cells. ST3GAL1 is a sialyltransferase that adds sialic acid to core 1 glycans, thereby terminating glycan chain extension. In breast carcinomas, overexpression of ST3GAL1 promotes tumorigenesis and correlates with increased tumor grade. In pursuing the role of ST3GAL1 in breast cancer using ST3GAL1-siRNA to knockdown ST3GAL1, we identified CD55 to be one of the potential target proteins of ST3GAL1. CD55 is an important complement regulatory protein, preventing cells from complement-mediated cytotoxicity. CD55 had one N-linked glycosylation site in addition to a Ser/Thr-rich domain, which was expected to be heavily O-glycosylated. Detailed analyses of N- and O-linked oligosaccharides of CD55 released from scramble or ST3GAL1 siRNA–treated breast cancer cells by tandem mass spectrometry revealed that the N-glycan profile was not affected by ST3GAL1 silencing. The O-glycan profile of CD55 demonstrated a shift in abundance to nonsialylated core 1 and monosialylated core 2 at the expense of the disialylated core 2 structure after ST3GAL1 silencing. We also demonstrated that O-linked desialylation of CD55 by ST3GAL1 silencing resulted in increased C3 deposition and complement-mediated lysis of breast cancer cells and enhanced sensitivity to antibody-dependent cell-mediated cytotoxicity. These data demonstrated that ST3GAL1-mediated O-linked sialylation of CD55 acts like an immune checkpoint molecule for cancer cells to evade immune attack and that inhibition of ST3GAL1 is a potential strategy to block CD55-mediated immune evasion.
- Published
- 2021
6. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells
- Author
-
Tan-Chi Fan, Nai-Chuan Chang, Jyh-Cherng Yu, Hui Ling Yeo, John Yu, Ming-Yi Ho, Alice L. Yu, Wen-Der Lin, and Huan-Ming Hsu
- Subjects
0301 basic medicine ,Cancer Research ,Glial Cell Line-Derived Neurotrophic Factor Receptors ,beta-Galactoside alpha-2,3-Sialyltransferase ,endocrine system diseases ,Estrogen receptor ,Breast Neoplasms ,Kaplan-Meier Estimate ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Cell Line, Tumor ,medicine ,Glial cell line-derived neurotrophic factor ,Humans ,Gene silencing ,Protein kinase B ,Feedback, Physiological ,Gene knockdown ,biology ,urogenital system ,Cell growth ,Proto-Oncogene Proteins c-ret ,medicine.disease ,Sialyltransferases ,Gene Expression Regulation, Neoplastic ,HEK293 Cells ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,MCF-7 Cells ,Cancer research ,biology.protein ,Phosphorylation ,Female ,RNA Interference ,Signal Transduction - Abstract
GFRA1 and RET are overexpressed in estrogen receptor (ER)-positive breast cancers. Binding of GDNF to GFRA1 triggers RET signaling leading to ER phosphorylation and estrogen-independent transcriptional activation of ER-dependent genes. Both GFRA1 and RET are membrane proteins which are N-glycosylated but no O-linked sialylation site on GFRA1 or RET has been reported. We found GFRA1 to be a substrate of ST3GAL1-mediated O-linked sialylation, which is crucial to GDNF-induced signaling in ER-positive breast cancer cells. Silencing ST3GAL1 in breast cancer cells reduced GDNF-induced phosphorylation of RET, AKT and ERα, as well as GDNF-mediated cell proliferation. Moreover, GDNF induced transcription of ST3GAL1, revealing a positive feedback loop regulating ST3GAL1 and GDNF/GFRA1/RET signaling in breast cancers. Finally, we demonstrated ST3GAL1 knockdown augments anti-cancer efficacy of inhibitors of RET and/or ER. Moreover, high expression of ST3GAL1 was associated with poor clinical outcome in patients with late stage breast cancer and high expression of both ST3GAL1 and GFRA1 adversely impacted outcome in those with high grade tumors.
- Published
- 2018
7. Sialylation of vasorin by ST3Gal1 facilitates TGF-β1-mediated tumor angiogenesis and progression
- Author
-
Nai-Chuan Chang, Margaret Dah-Tsyr Chang, Chein‐Hung Chen, John Yu, Kowa Chen, Eric Sheng‐Wen Chen, Jen-Chine Wu, Jung-Tung Hung, Alice L. Yu, Ming-Yi Ho, Ruey-Jen Lin, Tan-Chi Fan, Wen-Der Lin, Guo-Shiou Liao, Jyh-Cherng Yu, and Hui Ling Yeo
- Subjects
Cancer Research ,beta-Galactoside alpha-2,3-Sialyltransferase ,Sialyltransferase ,Angiogenesis ,vasorin ,Breast Neoplasms ,Transforming Growth Factor beta1 ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,Molecular Cancer Biology ,angiogenesis ,sialylation ,0302 clinical medicine ,breast cancer ,Downregulation and upregulation ,Gene expression ,Human Umbilical Vein Endothelial Cells ,Animals ,Humans ,Breast ,RNA, Small Interfering ,Tube formation ,biology ,Neovascularization, Pathologic ,Membrane Proteins ,TGF‐β1 ,Survival Analysis ,Xenograft Model Antitumor Assays ,Sialyltransferases ,Sialic acid ,Up-Regulation ,Oncology ,chemistry ,Tumor progression ,030220 oncology & carcinogenesis ,ST3Gal1 ,biology.protein ,Cancer research ,Disease Progression ,MCF-7 Cells ,Sialic Acids ,Female ,Neoplasm Recurrence, Local ,Carrier Proteins ,Transforming growth factor ,Signal Transduction - Abstract
ST3Gal1 is a key sialyltransferase which adds α2,3‐linked sialic acid to substrates and generates core 1 O‐glycan structure. Upregulation of ST3Gal1 has been associated with worse prognosis of breast cancer patients. However, the protein substrates of ST3Gal1 implicated in tumor progression remain elusive. In our study, we demonstrated that ST3GAL1‐silencing significantly reduced tumor growth along with a notable decrease in vascularity of MCF7 xenograft tumors. We identified vasorin (VASN) which was shown to bind TGF‐β1, as a potential candidate that links ST3Gal1 to angiogenesis. LC‐MS/MS analysis of VASN secreted from MCF7, revealed that more than 80% of its O‐glycans are sialyl‐3T and disialyl‐T. ST3GAL1‐silencing or desialylation of VASN by neuraminidase enhanced its binding to TGF‐β1 by 2‐ to 3‐fold and thereby dampening TGF‐β1 signaling and angiogenesis, as indicated by impaired tube formation of HUVECs, suppressed angiogenesis gene expression and reduced activation of Smad2 and Smad3 in HUVEC cells. Examination of 114 fresh primary breast cancer and their adjacent normal tissues showed that the expression levels of ST3Gal1 and TGFB1 were high in tumor part and the expression of two genes was positively correlated. Kaplan Meier survival analysis showed a significantly shorter relapse‐free survival for those with lower expression VASN, notably, the combination of low VASN with high ST3GAL1 yielded even higher risk of recurrence (p = 0.025, HR = 2.967, 95% CI = 1.14–7.67). Since TGF‐β1 is known to transcriptionally activate ST3Gal1, our findings illustrated a feedback regulatory loop in which TGF‐β1 upregulates ST3Gal1 to circumvent the negative impact of VASN., What's new? The addition of sialic acid to glycoproteins is dysregulated in many cancers, and enhanced expression of one key enzyme, the sialyltransferase ST3Gal1, is associated with poor prognosis. Here, the authors identified the membrane protein vasorin as a new ST3Gal1 substrate and connect it with TGF‐β1‐induced signaling and angiogenesis in breast cancer. As silencing of ST3Gal1 dampened TGF‐β1 signaling and suppressed angiogenesis, development of ST3Gal1 inhibitors might be clinically useful to improve the prognosis of breast cancer patients.
- Published
- 2018
8. Highly Fluorescent Nanodiamonds Protein-Functionalized for Cell Labeling and Targeting
- Author
-
Ruey-Jen Lin, Be-Ming Chang, Alice L. Yu, Reiko T. Lee, Wen-Der Lin, Long-Jyun Su, Yuan C. Lee, Yan-Kai Tzeng, Hsin-Hung Lin, and Huan-Cheng Chang
- Subjects
chemistry.chemical_classification ,Streptavidin ,Materials science ,Bioconjugation ,Biocompatibility ,Conjugated system ,Condensed Matter Physics ,Fluorescence ,Electronic, Optical and Magnetic Materials ,Biomaterials ,chemistry.chemical_compound ,Biochemistry ,chemistry ,Electrochemistry ,Fluorescence microscope ,Glycoprotein ,Nanodiamond - Abstract
Fluorescent nanodiamond (FND) is attracting much attention as a bioimaging agent because of its inherent biocompatibility and superior optical properties (e.g., excellent photostability and far-red emission). However, for practical use in life science research, some issues such as higher brightness and ease of bioconjugation have to be solved. Here, it is shown that the 100-nm FND particles fabricated by using nitrogen-rich type Ib diamonds and high-energy proton irradiation are highly fluorescent and readily functionalizable with proteins for biological applications. In the first approach, acid-treated FND is noncovalently coated with glycoproteins or neoglycoproteins (i.e., proteins chemically modified with multiple sugar residues) for targeting hepatocytes via carbohydrate receptors. In the second approach, FND is first PEGylated and then covalently conjugated with streptavidin, to which biotin-labeled antibodies of interest are linked. High targeting specificity of the bioconjugated FND is demonstrated with the human hepatoma cell line, HepG2, and breast cancer cell lines, ASB145-1R, MCF-7, and MDA-MB-231 cells. These approaches should be widely applicable to a variety of situations for specific targeting and labeling of cells.
- Published
- 2013
9. Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells
- Author
-
Shao-Yong Huang, Ying-Hue Lee, Chih-Hsien Chiu, and Wen-Der Lin
- Subjects
G protein ,Adipose tissue ,Biology ,Research Communications ,Mice ,chemistry.chemical_compound ,GTP-Binding Proteins ,Adipocyte ,CCAAT-Enhancer-Binding Protein-alpha ,Genetics ,medicine ,Animals ,Alleles ,CCAAT-Enhancer-Binding Protein-beta ,Fatty liver ,food and beverages ,Fat cell differentiation ,medicine.disease ,Molecular biology ,Mitochondria ,Sterol regulatory element-binding protein ,chemistry ,Mitochondrial biogenesis ,Adipogenesis ,lipids (amino acids, peptides, and proteins) ,Energy Metabolism ,Developmental Biology - Abstract
At its simplest level, obesity is a disorder of energy balance, where energy intake exceeds energy expenditure; as a consequence, the excess energy is stored in the form of fat in adipocytes. The primary onset mechanisms are dietary and/or genetic (Kopelman 2000). Of those known genetic factors involved in determining adiposity in animals, many are regulatory and exert their effect directly on adipocyte differentiation and development (Rosen et al. 2000; Flier 2004). These factors include CCAAT/enhancer-binding proteins (C/EBPs), SREBP, and PPARγ, whose concerted action during adipogenesis leads to the development of fat-laden mature adipocytes (Rosen et al. 2000). The C/EBP family consists of five members, of which C/EBPα, C/EBPβ, and C/EBPδ have a profound impact on fat cell differentiation (Yeh et al. 1995). During adipogenesis, C/EBP family functions in a transcriptional cascade, in which the early and transiently expressed C/EBPβ and C/EBPδ activate transcription of PPARγ. PPARγ is then responsible for the expression of C/EBPα (Wu et al. 1996; Rosen et al. 1999). Subsequently, PPARγ and C/EBPα, together with SREBP, work synergistically to transactivate expression of most or all of the genes encoding for factors, such as fatty-acid synthase and adipocyte-specific fatty acid-binding protein aP2, which characterize the fat cell phenotype (Speigelman et al. 1993). In this study, we used previously manipulated gene knock-in mice, known as β/β mice, in which the C/EBPα gene has been replaced by the C/EBPβ gene (referred here as β/β allele) to study their function in tissues (Chen et al. 2000). β/β mice are lean, and despite markedly reduced fat storage in their fat cells, they do not develop hyperlipidemia or fatty liver, commonly found in the forced leaness that typically causes the liver to take up and store fatty acids when their circulating levels are elevated (Moitra et al. 1998; Shimomura et al. 1998; Chen et al. 2000). We monitored closely the physiology and lifespan of the lean β/β mice and undertook mechanistic studies to understand the effect of β/β allele in energy metabolism. We found that the β/β allele caused an increase in mitochondrial biogenesis only in fat cells of white adipose tissues (WAT), and this WAT specifically enhanced mitochondrial biogenesis was possibly elicited by the markedly elevated expression of G protein α stimulatory subunit (Gαs).
- Published
- 2004
10. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus
- Author
-
Jing-Yan Cheng, Chi-Huey Wong, Wen-Der Lin, Jung-Tung Hung, Kun-Hsien Lin, Ming-Wei Chen, Alice L. Yu, Yi-Chieh Tsai, Jing-Rong Huang, and Jia-Tsrong Jan
- Subjects
Influenza vaccine ,medicine.medical_treatment ,Hemagglutinin (influenza) ,Hemagglutinin Glycoproteins, Influenza Virus ,CD8-Positive T-Lymphocytes ,medicine.disease_cause ,Antibodies, Viral ,Injections, Intramuscular ,Virus ,Microbiology ,DNA vaccination ,Interferon-gamma ,Adjuvants, Immunologic ,Orthomyxoviridae Infections ,Virology ,medicine ,Vaccines, DNA ,Animals ,Pharmacology ,Mice, Inbred BALB C ,biology ,Influenza A Virus, H5N1 Subtype ,Electroporation ,Antibodies, Neutralizing ,Survival Analysis ,Influenza A virus subtype H5N1 ,Killer Cells, Natural ,Titer ,Disease Models, Animal ,Influenza Vaccines ,biology.protein ,Female ,Glycolipids ,Adjuvant - Abstract
H5N1 influenza virus is a highly pathogenic virus, posing a pandemic threat. Previously, we showed that phenyl analogs of α-galactosylceramide (α-GalCer) displayed greater NKT stimulation than α-GalCer. Here, we examined the adjuvant effects of one of the most potent analogs, C34, on consensus hemagglutinin based DNA vaccine (pCHA5) for H5N1 virus. Upon intramuscular electroporation of mice with pCHA5 with/without various α-GalCer analogs, C34-adjuvanted group developed the highest titer against consensus H5 and more HA-specific IFN-γ secreting CD8 cells (203±13.5) than pCHA5 alone (152.6±13.7, p0.05). Upon lethal challenge of NIBRG-14 virus, C34-adjuvanted group (84.6%) displayed higher survival rate than pCHA5 only group (46.1%). In the presence of C34 as adjuvant, the antisera displayed broader and greater neutralizing activities against virions pseudotyped with HA of clade 1, and 2.2 than pCHA5 only group. Moreover, to simulate an emergency response to a sudden H5N1 outbreak, we injected mice intramuscularly with single dose of a new consensus H5 (pCHA5-II) based on 1192 full-length H5 sequences, with C34 as adjuvant. The latter not only enhanced the humoral immune response and protection against virus challenge, but also broadened the spectrum of neutralization against pseudotyped HA viruses. Our vaccine strategy can be easily implemented for any H5N1 virus outbreak by single IM injection of a consensus H5 DNA vaccine based on updated HA sequences using C34 as an adjuvant.
- Published
- 2013
11. Looping adjacent nodes on multistage interconnection networks
- Author
-
Wen-Der Lin and Eric W. S. Chen
- Subjects
Loop (graph theory) ,Interconnection ,Parallel processing (DSP implementation) ,Hardware and Architecture ,Computer science ,Distributed computing ,Multistage interconnection networks ,Power of two ,Link (geometry) ,Topology ,Dissemination ,Telecommunications network ,Software - Abstract
Many parallel applications of image processing and linear system problems require multinode broadcasts over a cluster of adjacent nodes of a multi-computer system. In this paper, we propose an efficient solution to the multinode broadcast problem for the multistage interconnection network. Our approach is to connect adjacent nodes through the network to form a loop configuration by which nodes are able to disseminate messages in a highly pipelined fashion. Although barrel shift can achieve loop configurations, it works only in the special case: the length of adjacent nodes is a power of two. Looping adjacent nodes of arbitrary length is still a problem. The difficulty lies in resolving link conflicts that arise from creating paths for loops. We present a procedure for structuring adjacent nodes of variable length into a loop. It first divides a given set of adjacent nodes into two subsets, forming two initial loops on the two subsets. Then it merges the two loops into a single loop without incurring conflicts. In this paper, we also consider looping modulus-adjacent nodes of variable lenght.
- Published
- 1996
12. Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model
- Author
-
Jung-Tung Hung, Steve R. Roffler, Sheng-Chuan Hsi, Tian-Lu Cheng, Shey-Cherng Tsou, Huey-Kang Sytwu, Kuo-Liang Shen, Chi-Hsien Wang, Hsiang-Sheng Sung, and Wen-Der Lin
- Subjects
Blood Glucose ,Male ,BALB 3T3 Cells ,medicine.medical_treatment ,Immunoglobulin Variable Region ,Gene Expression ,Nod ,Lymphocyte Activation ,Receptors, Tumor Necrosis Factor ,Mice ,Mice, Inbred NOD ,Immunology and Allergy ,Insulin ,Promoter Regions, Genetic ,Immunoglobulin Fragments ,NOD mice ,Glutamate Decarboxylase ,Genetic Carrier Screening ,Experimental autoimmune encephalomyelitis ,Antibodies, Monoclonal ,Isoenzymes ,Blotting, Southern ,Female ,Immunotherapy ,medicine.medical_specialty ,Transgene ,Recombinant Fusion Proteins ,Immunology ,Genetic Vectors ,Mice, Transgenic ,Receptors, Cell Surface ,Receptors, Nerve Growth Factor ,Transfection ,Tumor Necrosis Factor Receptor Superfamily, Member 9 ,Sex Factors ,Antigens, CD ,Glycosuria ,Diabetes mellitus ,Internal medicine ,medicine ,Animals ,Humans ,Pancreas ,Type 1 diabetes ,business.industry ,medicine.disease ,Peptide Fragments ,Disease Models, Animal ,Endocrinology ,Diabetes Mellitus, Type 1 ,business ,Insulitis ,Spleen - Abstract
Various therapeutic strategies have been developed to tolerize autoreactive T cells and prevent autoimmune pathology in type 1 diabetes. 4-1BB, a member of the tumor necrosis factor receptor (TNFR) superfamily, is a costimulatory receptor primarily expressed on activated T cells. The administration of an agonistic anti-4-1BB antibody (2A) dramatically reduced the incidence and severity of experimental autoimmune encephalomyelitis (EAE). Treatment with the same antibody in Fas-deficient MRL/lpr mice blocked lymphadenopathy and lupus-like autoimmune processes. Paradoxically, transgenic non-obese diabetic (NOD) mice overexpressing membrane-bound agonistic single-chain anti-4-1BB Fv in pancreatic beta cells developed more severe diabetes than their non-transgenic littermates, with earlier onset, faster diabetic processes, and higher mortality. Forty percent of transgenic mice developed diabetes by 4 weeks of age, compared with their control littermates, which first exhibited diabetes at 14 weeks. The frequency of diabetes in female transgenics reached 70% by 8 weeks of age. Most female transgenic mice died around 12 weeks. Consistent with this, transgenic mice developed earlier and more severe insulitis and showed stronger GAD-specific T-cell responses, compared with age-matched control littermates. Our results indicate an adverse effect of transgenic anti-4-1BB scFv in NOD mice and suggest a potential risk of this anti-4-1BB-based immunotherapy for autoimmune diseases.
- Published
- 2003
13. Chimeras of p14ARF and p16: Functional Hybrids with the Ability to Arrest Growth
- Author
-
Alice L. Yu, Richard T. Williams, Wen-Der Lin, Mitchell B. Diccianni, Ayse Batova, Huan-Hsien Kuo, and Lisa M. Barnhill
- Subjects
Mutant Chimeric Proteins ,lcsh:Medicine ,Biology ,Stress Signaling Cascade ,Cell Growth ,Cyclin D1 ,p14arf ,Genetic Mutation ,Cyclin-dependent kinase ,CDKN2A ,Cell Line, Tumor ,Cyclins ,Tumor Suppressor Protein p14ARF ,Molecular Cell Biology ,Genetics ,Cancer Genetics ,Humans ,lcsh:Science ,Melanoma ,Cyclin-Dependent Kinase Inhibitor p16 ,Cell Proliferation ,Cyclin ,Multidisciplinary ,Base Sequence ,Protein Kinase Signaling Cascade ,Cell growth ,lcsh:R ,Cell Cycle ,Mutation Types ,Cyclin-Dependent Kinase 4 ,Exons ,Cell cycle ,Flow Cytometry ,Fusion protein ,Molecular biology ,Signaling Cascades ,Mutation ,biology.protein ,lcsh:Q ,Tumor Suppressor Protein p53 ,Cell Division ,Cytometry ,Research Article ,Signal Transduction - Abstract
The INK4A locus codes for two independent tumor suppressors, p14ARF and p16/CDKN2A, and is frequently mutated in many cancers. Here we report a novel deletion/substitution from CC to T in the shared exon 2 of p14ARF/p16 in a melanoma cell line. This mutation aligns the reading frames of p14ARF and p16 mid-transcript, producing one protein which is half p14ARF and half p16, chimera ARF (chARF), and another which is half p16 and half non-p14ARF/non-p16 amino acids, p16-Alternate Carboxyl Terminal (p16-ACT). In an effort to understand the cellular impact of this novel mutation and others like it, we expressed the two protein products in a tumor cell line and analyzed common p14ARF and p16 pathways, including the p53/p21 and CDK4/cyclin D1 pathways, as well as the influence of the two proteins on growth and the cell cycle. We report that chARF mimicked wild-type p14ARF by inducing the p53/p21 pathway, inhibiting cell growth through G2/M arrest and maintaining a certain percentage of cells in G1 during nocodazole-induced G2 arrest. chARF also demonstrated p16 activity by binding CDK4. However, rather than preventing cyclin D1 from binding CDK4, chARF stabilized this interaction through p21 which bound CDK4. p16-ACT had no p16-related function as it was unable to inhibit cyclin D1/CDK4 complex formation and was unable to arrest the cell cycle, though it did inhibit colony formation. We conclude that these novel chimeric proteins, which are very similar to predicted p16/p14ARF chimeric proteins found in other primary cancers, result in maintained p14ARF-p53-p21 signaling while p16-dependent CDK4 inhibition is lost.
- Published
- 2014
14. Abstract 2305: Role of ST3Gal1 sialyltransferase in breast cancer cells
- Author
-
Alice L. Yu, Zhin-mei Chen, Lan-Yi Chang, Tan-chi Fan, Kay-Hooi Khoo, Wen-der Lin, and Chih-hao Chang
- Subjects
Cancer Research ,Sialyltransferase ,Cancer ,Biology ,medicine.disease ,Sialic acid ,chemistry.chemical_compound ,Breast cancer ,Oncology ,Antigen ,chemistry ,Cancer cell ,Immunology ,medicine ,Cancer research ,biology.protein ,Breast carcinoma ,MUC1 - Abstract
Alteration of glycan structures on glycoproteins or glycolipids is a common phenomenon observed in malignancy. The premature sialylation of core carbohydrate structure leading to shorter truncated glycans has been well documented. Mucin O-glycans from normal breast are mostly composed of elongated core 2 structures. It has been shown that MUC1 O-glycans from breast cancer cell lines are often truncated and mainly consist of core 1-based structures from mass spectrometry sequencing. It may be due to down-regulated C2GnT (core 2 enzymes) or increased sialyltransferase activities which add sialic acid in an α2,3 linkage to Galβ1-3GalNAc, producing sialyl3 T antigen, which is no longer recognized by C2GnT as a substrate donor. Six different α2,3-sialyltransferases catalyze the transfer of sialic acids to Gal. Among which, ST3Gal1 and ST3Gal2 are capable of producing sialyl3 T antigens; however, only the expression of ST3Gal1 mRNA is elevated in primary breast carcinoma cells compared to normal or benign breast tissues. In ductal carcinomas, the expression of ST3Gal1 appeared to correlate with histology grade. However, not much is known about the role of ST3Gal1 in breast cancers. We investigated the role of ST3Gal1-mediated sialylation in the function of proteins and further characterize the molecular mechanism underlying ST3Gal1-mediated cancer metastasis. To confirm the relationship of ST3Gal1 expression in breast cancers, we performed qPCR analysis of sialyltransferase gene expression in 93 breast cancer patients. ST3Gal1 expression was statistically higher in ER-, PR-, and HER2-negative category (p Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2305. doi:10.1158/1538-7445.AM2011-2305
- Published
- 2011
15. Development of a Risk-Adjusted Capitation Model Based on Principal Inpatient Diagnoses in Taiwan
- Author
-
林文德(Wen-Der Lin), 張睿詒(Ray-E Chang), 謝其政(Chi-Jen Hsieh), 楊志良(Chih-Liang Yaung), and TUNG-LIANG CHIANG
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.